Physician profile
Tom A Lassar
NPI 1487670048
$21,214.58
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,649 · 2020: $10K · 2021: $618 · 2023: $266 · 2024: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $16,689.89 | 2019-2023 | Cleviprex |
| Janssen Scientific Affairs, LLC | $2,000.00 | 2020 | |
| Abiomed | $285.44 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $251.65 | 2019-2021 | |
| Pfizer INC. | $247.76 | 2019 | |
| Abbott Laboratories | $200.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $192.17 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $160.80 | 2019 | |
| Philips North America LLC | $146.69 | 2019-2023 | |
| Teleflex LLC | $145.03 | 2023 | Guideliner |
| Inari Medical, INC. | $137.39 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heartflow, INC. | $125.17 | 2019 | |
| W. L. Gore & Associates, INC. | $118.22 | 2019 | |
| Boston Scientific Corporation | $111.30 | 2019 | |
| Edwards Lifesciences Corporation | $109.72 | 2024 | Mitris Resilia Mitral Valve |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.81 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.34 | 2019 | |
| Biotronik INC. | $52.90 | 2019 | |
| Lantheus Medical Imaging, INC. | $30.99 | 2019-2021 | |
| Medtronic Vascular, INC. | $24.93 | 2019 | |
| Irhythm Technologies, INC. | $23.42 | 2019 | |
| Amarin Pharma, INC. | $14.28 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.88 | 2019 | |
| Amgen INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Lassar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.